Pricing Log in Create free account

Apollomics Inc. (APLM) vs Gain Therapeutics, Inc. (GANX)

Apollomics Inc. and Gain Therapeutics, Inc. are both Biotechnology companies. Apollomics Inc. and Gain Therapeutics, Inc. are of similar size ($61.2M and $58.1M). Across the 9 metrics below, Apollomics Inc. leads on 8 and Gain Therapeutics, Inc. on 1.

Valuation

Metric APLM GANX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 276.65 9.71
P/B n/m 4.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 211.41 9.21
Earnings yield (0.28%) (39.68%) (33.15%)
Free cash flow yield 0.00% (35.12%) (25.50%)

Profitability

Metric APLM GANX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (268.30%) (56.36%)
Return on assets 0.00% (159.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APLM GANX Biotechnology median
Revenue growth (TTM) — 18.36% 6.02%
EPS growth (last fiscal year) 85.66% 31.46% 30.26%
Revenue growth, 5-year CAGR 32.77% 21.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APLM GANX Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 0.96 4.36 4.72
Net debt to EBITDA 0.37 1.10 0.96

Dividend

Metric APLM GANX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APLM GANX Biotechnology median
Market cap 61.22m 58.05m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack